WallStreetZenWallStreetZen

NASDAQ: LGND
Ligand Pharmaceuticals Inc Stock Ownership - Who owns Ligand Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ligand Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew ReardonCLO Secretary2025-06-10500$114.54
$57.27kSell
Martine ZimmermannDirector2025-06-06188$105.99
$19.93kSell
Andrew ReardonCLO Secretary2025-05-151,000$104.00
$104.00kSell
Todd C. DavisChief Executive Officer2025-05-091,680$104.57
$175.68kBuy
Octavio EspinozaChief Financial Officer2025-05-09500$104.40
$52.20kBuy
Todd C. DavisChief Executive Officer2025-05-095,523$105.67
$583.63kBuy
Todd C. DavisChief Executive Officer2025-05-092,307$104.53
$241.15kBuy
Octavio EspinozaChief Financial Officer2025-05-091,000$103.89
$103.89kBuy
Stephen L. SabbaDirector2025-04-012,406$52.30
$125.83kBuy
Octavio EspinozaChief Financial Officer2025-03-045,000$115.03
$575.15kSell

1 of 7

LGND insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LGND insiders and whales buy or sell their stock.

LGND Shareholders

What type of owners hold Ligand Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P328.26%63,334,719$7.13BInsider
David M. Knott65.36%12,611,277$1.42BInsider
Daniel S. Loeb50.56%9,754,756$1.10BInsider
Investment 10 LLC18.57%3,582,065$402.98MInsider
Blackrock Inc15.14%2,920,235$328.53MInstitution
Vanguard Group Inc10.65%2,055,732$231.27MInstitution
Janus Henderson Group PLC5.33%1,027,549$115.60MInstitution
Macquarie Group Ltd4.70%906,227$101.95MInstitution
Dimensional Fund Advisors LP3.86%744,930$83.80MInstitution
State Street Corp3.77%727,125$81.80MInstitution

1 of 3

LGND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LGND16.92%83.08%Net SellingNet Buying
BCRX82.45%17.55%Net SellingNet Selling
ARWR74.85%9.93%Net SellingNet Selling
VCEL91.20%8.80%Net SellingNet Buying
DNLI60.00%40.00%Net Selling
View Top Biotech Stocks

Ligand Pharmaceuticals Stock Ownership FAQ

Who owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals (NASDAQ: LGND) is owned by 96.72% institutional shareholders, 474.95% Ligand Pharmaceuticals insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Ligand Pharmaceuticals shareholder, owning 63.33M shares representing 328.26% of the company. Bvf Partners L P's Ligand Pharmaceuticals shares are currently valued at $7.13B.

If you're new to stock investing, here's how to buy Ligand Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.